TARO PHARMACEUTICAL INDUSTRIES LTD Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2020 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Taro Pharmaceutical Industries Ltd quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2020 to Q1 2023.
  • Taro Pharmaceutical Industries Ltd Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2023 was $3.87M, a 28.6% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $3.87M -$1.55M -28.6% Mar 31, 2023 20-F 2023-06-29
Q1 2022 $5.42M +$2.69M +98.7% Mar 31, 2022 20-F 2023-06-29
Q1 2021 $2.73M +$534K +24.3% Mar 31, 2021 20-F 2022-07-25
Q1 2020 $2.2M Mar 31, 2020 20-F 2021-06-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.